Transformation of residual mature ovarian teratoma to adenocarcinoma 10 years after initial treatment.
A patient with a residual mature solid ovarian teratoma, which underwent malignant transformation to an adenocarcinoma 10 years after previous successful treatment, is presented. This case history illustrates that patients with residual mature disease require long term follow-up.
Ahmed
F Y
FY
Royal Marsden Hospital, London, UK.
Gore
M E
ME
Shepherd
J
J
Fisher
C
C
D000230:Adenocarcinoma / Q000473:pathology* / Q000556:secondary; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D017024:Chemotherapy, Adjuvant; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008113:Liver Neoplasms / Q000556:secondary; D008137:Longitudinal Studies; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000601:surgery; D013724:Teratoma / Q000473:pathology* / Q000556:secondary / Q000601:surgery